AlphaSense Webinar Recap: AI For Investor Relations

AlphaSense's Kate Thunnissen and Chris Ackerson discuss augmented intelligence and its impact on Investor Relations workflows.

Read now
filter by

BIO CEO 2019: The Future Of IPOs And M&As In Biotech

AlphaSense Staff

At the BIO CEO & Investor Conference 2019, AlphaSense discusses the shifting M&A landscape following a record-setting year of biotech IPOs.

Read post
{{ post.topic }}
{{ }}

{{ post.title }}

{{ }} {{ }}

{{ post.intro }}

Read post

Schedule a demo